These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 19456273)
21. A glutamatergic component of lead toxicity in adult brain: the role of astrocytic glutamate transporters. Struzyńska L Neurochem Int; 2009; 55(1-3):151-6. PubMed ID: 19428820 [TBL] [Abstract][Full Text] [Related]
22. Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy. Zaitsev AV; Smolensky IV; Jorratt P; Ovsepian SV CNS Drugs; 2020 Nov; 34(11):1089-1103. PubMed ID: 32926322 [TBL] [Abstract][Full Text] [Related]
23. Can selective ligands for glutamate binding proteins be rationally designed? Natale NR; Magnusson KR; Nelson JK Curr Top Med Chem; 2006; 6(8):823-47. PubMed ID: 16719820 [TBL] [Abstract][Full Text] [Related]
25. Structure-activity-relationship study of N-acyl-N-phenylpiperazines as potential inhibitors of the Excitatory Amino Acid Transporters (EAATs): improving the potency of a micromolar screening Hit is not truism. Huynh TH; Demmer CS; Abrahamsen B; Marcher E; Frykman M; Jensen AA; Bunch L Springerplus; 2013; 2():112. PubMed ID: 25530930 [TBL] [Abstract][Full Text] [Related]
26. Structure-activity relationship study of first selective inhibitor of excitatory amino acid transporter subtype 1: 2-Amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101). Erichsen MN; Huynh TH; Abrahamsen B; Bastlund JF; Bundgaard C; Monrad O; Bekker-Jensen A; Nielsen CW; Frydenvang K; Jensen AA; Bunch L J Med Chem; 2010 Oct; 53(19):7180-91. PubMed ID: 20857912 [TBL] [Abstract][Full Text] [Related]
27. Stereoselective chemoenzymatic synthesis of the four stereoisomers of l-2-(2-carboxycyclobutyl)glycine and pharmacological characterization at human excitatory amino acid transporter subtypes 1, 2, and 3. Faure S; Jensen AA; Maurat V; Gu X; Sagot E; Aitken DJ; Bolte J; Gefflaut T; Bunch L J Med Chem; 2006 Nov; 49(22):6532-8. PubMed ID: 17064071 [TBL] [Abstract][Full Text] [Related]
28. Roles and regulation of glutamate transporters in the central nervous system. O'Shea RD Clin Exp Pharmacol Physiol; 2002 Nov; 29(11):1018-23. PubMed ID: 12366395 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological characterization of (4R)-alkyl glutamate analogues at the ionotropic glutamate receptors--focus on subtypes iGlu(5-7). Bunch L; Gefflaut T; Alaux S; Sagot E; Nielsen B; Pickering DS Eur J Pharmacol; 2009 May; 609(1-3):1-4. PubMed ID: 19285062 [TBL] [Abstract][Full Text] [Related]
31. [Structural and functional characteristics of glutamate transporters: how they are related to epilepsy and oxidative stress]. Medina-Ceja L; Guerrero-Cazares H; Canales-Aguirre A; Morales-Villagran A; Feria-Velasco A Rev Neurol; 2007 Sep 16-30; 45(6):341-52. PubMed ID: 17899516 [TBL] [Abstract][Full Text] [Related]
32. Functional importance of GGXG sequence motifs in putative reentrant loops of 2HCT and ESS transport proteins. Dobrowolski A; Lolkema JS Biochemistry; 2009 Aug; 48(31):7448-56. PubMed ID: 19594131 [TBL] [Abstract][Full Text] [Related]
33. No genetic association between the SLC1A2 gene and Japanese patients with schizophrenia. Nagai Y; Ohnuma T; Karibe J; Shibata N; Maeshima H; Baba H; Hatano T; Hanzawa R; Arai H Neurosci Lett; 2009 Oct; 463(3):223-7. PubMed ID: 19660525 [TBL] [Abstract][Full Text] [Related]